The British Council, MUTEK and Somerset House Studios are launching an open call for AMPLIFY Digital Arts Initiative 2020 for women-identified artists working in the digital arts, VR, AR, immersive storytelling and electronic music sectors based in Argentina, Canada, and the UK.
AMPLIFY D.A.I is an initiative developed by the British Council in partnership with MUTEK and Somerset House Studios in the UK. Since 2018, the programme has connected an active network in Argentina, Canada, Mexico, Venezuela, Peru and the UK.
AMPLIFY D.A.I is a platform that creates international visibility in the industry for women-identified artists and curators. The programme offers networking opportunities, showcases, exhibitions and performances, residencies, workshops, creative labs and field trips.
The first AMPLIFY D.A.I programme took place in 2018 engaging 20 selected artists in MUTEK editions in Montréal, Buenos Aires and Mexico City, finally reconnecting in the UK with a residency at Somerset House Studios in 2019.
For the 2019 edition, the programme featured a new cohort of 20 artists and professionals from Argentina, Canada, Peru and the UK, who participated in MUTEK editions in Montréal, Buenos Aires, and at Espacio Fundación Telefónica Lima in Peru. Selected participants from the 2019 cohort will take part in workshops and showcase their work at Somerset House Studios later this year.
For the 2020 edition, the artists will be selected through an open call, from January 21 to February 16, 2020.
We invite interested artists to apply through the link below, where you will find more information around criteria, eligibility and what is included in the programme.
We are committed to equal opportunities and to reflect diversity in our programming and at every level within our organisations. This initiative is part of our wider strategy to support the participation of women-identified artists and curators to increase gender equality in the digital arts sector.
For Canadian applicants, click here - https://forms.gle/6VWFTVwaKpxAxeHb9